Vantage BioTrials at Bio-Europe
November 9–11, 2026 | Cologne, Germany
Vantage BioTrials is pleased to announce that Vatché Bartekian, President, will attend BIO-Europe 2026 in Cologne, Germany.
BIO-Europe is Europe’s largest and longest-running partnering conference for the global biotechnology and biopharmaceutical industry. The event is expected to bring together more than 5,800 participants representing over 3,200 companies from more than 60 countries.
If your organization is preparing for a Phase I–IV clinical trial, evaluating a clinical research organization or planning an upcoming clinical development milestone, Vatché welcomes the opportunity to discuss how Vantage BioTrials can support your program through disciplined execution, proactive risk management and collaborative clinical trial leadership.
Planning a clinical trial? Meet with Vantage BioTrials at BIO-Europe 2026 to discuss how our Quality-by-Design approach and structured operational oversight can help advance your development program.
Why Meet with Vantage BioTrials at BIO-Europe?
Selecting the right CRO involves more than outsourcing clinical trial activities. It requires a partner that can anticipate operational challenges, protect study quality and maintain clear oversight throughout the clinical development lifecycle.
Vantage BioTrials combines Quality-by-Design principles, risk-based quality management and experienced clinical operations leadership to help sponsors translate development strategies into practical and reliable trial execution.
Our collaborative operating model is designed to provide:
- Structured clinical trial governance
- Quality-by-Design implementation
- Proactive risk identification and mitigation
- Experienced project management and clinical monitoring
- Regulatory and ethics submission support
- Vendor oversight and performance management
- Inspection readiness and quality management
- Protection of patient safety and data integrity
Whether supporting an emerging biotechnology company entering clinical development or an established sponsor managing a complex multinational study, our team works as an extension of the sponsor organization and provides solutions aligned with the needs, risks and objectives of each program.
Who We Would Like to Meet
Vantage BioTrials welcomes discussions with:
- Biotechnology companies preparing for first-in-human or early-phase studies
- Pharmaceutical sponsors seeking responsive and experienced CRO support
- Medical device and diagnostic developers
- Radiopharmaceutical and nuclear medicine innovators
- Companies considering clinical development in Canada or North America
- Organizations planning multinational Phase I–IV programs
- Investors and strategic partners supporting clinical-stage companies
Clinical Trial Services and Expertise
Vantage BioTrials provides clinical trial management and operational oversight services across early- and late-phase development programs.
Our capabilities include:
- Clinical project management
- On-site and remote clinical monitoring
- Risk-Based Quality Management
- Site feasibility and selection
- Study start-up
- Regulatory and ethics submissions
- Site management and participant recruitment support
- Vendor oversight
- Trial Master File oversight
- Quality management and inspection readiness
- Medical device clinical studies
- Radiopharmaceutical and imaging-based trials
- Phase I–IV clinical development
Meet Vatché Bartekian
President, Vantage BioTrials
With more than 28 years of experience in the pharmaceutical and biotechnology sectors, Vatché Bartekian brings extensive expertise in global drug development and the operational execution of complex clinical programs.
His leadership emphasizes scientific integrity, proactive risk identification and mitigation, structured governance and disciplined trial execution.
At BIO-Europe 2026, Vatché looks forward to meeting with biotechnology and pharmaceutical executives to discuss:
- Clinical development strategy and operational planning
- Risk-based approaches to complex trial execution
- Canadian and North American clinical development opportunities
- Sponsor oversight and CRO governance
- Quality-by-Design implementation
- Medical device, diagnostic and radiopharmaceutical programs
- Early- through late-phase clinical trial support
Why Attend BIO-Europe 2026?
BIO-Europe is a leading global forum for biopharmaceutical partnering. The 2026 program is expanding beyond traditional business development and investment discussions to include clinical strategy, regulatory developments and manufacturing considerations.
The conference brings together biotechnology and pharmaceutical companies, investors, academic organizations and industry service providers for scheduled one-to-one meetings, educational sessions and strategic networking opportunities. Partnering meetings are facilitated through the partneringONE platform.
For clinical-stage companies, the event provides an opportunity to identify potential development partners, evaluate service providers and establish relationships that can support future clinical and commercial milestones.
Schedule a Meeting at BIO-Europe 2026
If you will be attending BIO-Europe 2026, we invite you to schedule a meeting with Vatché Bartekian.
We would welcome the opportunity to learn about your clinical development objectives and discuss how Vantage BioTrials may support your program through experienced leadership, proactive risk management and disciplined clinical trial execution.
Email: [email protected]
About Vantage BioTrials
Vantage BioTrials is a Canadian clinical research organization specializing in clinical trial management, operational oversight, Quality-by-Design and proactive risk management.
We collaborate with biotechnology, pharmaceutical and medical device sponsors to support early-late phase clinical trials while maintaining rigorous standards of patient safety, regulatory compliance and data integrity.